Business Context and Reporting Period
Company: ProKidney Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 18, 2026
Reporting Period: The filing announces financial results for the fiscal year ended December 31, 2025.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not include the specific figures within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms the issuance of a press release regarding the 2025 year-end results.
Guidance, Outlook, and Risks
Management Commentary: The filing states that a press release was issued on March 18, 2026, to announce the results. Specific commentary, guidance, or outlook details are contained in the referenced Exhibit 99.1 and are not present in this summary text.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 18, 2026) for actual revenue, net income, and cash flow figures for the year ended December 31, 2025.
- Verify the specific year-over-year growth rates and margin trends in the full press release.
- Check for any forward-looking statements or updated guidance included in the press release.
- Confirm the company's liquidity position and debt obligations as detailed in the full financial results.